shortagewatch

Home / Nervous system / Lasmiditan

ATC N02CC08 · Selective Serotonin (5Ht1) Agonists · updated 2 Nov 2026

Lasmiditan shortage

As of 2 Nov 2026, Lasmiditan has a reported shortage in 1 of the 16 countries we track (United States), covering 6 products from 1 company.

Is there a Lasmiditan shortage?

Yes. As of 2 Nov 2026, Lasmiditan is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16
Products6packs or presentations
Companies11 listed
Short since3 Nov 202512 months ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States6 products shortCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

United States
2026Reyvow, Tablet, 100 mg (NDC 0002-4491-08)Reyvow, Tablet, 100 mg (NDC 0002-4491-08)Reyvow, Tablet, 100 mg (NDC 0002-4491-61)Reyvow, Tablet, 100 mg (NDC 0002-4491-61)Reyvow, Tablet, 100 mg (NDC 0002-4491-62)Reyvow, Tablet, 100 mg (NDC 0002-4491-62)Reyvow, Tablet, 50 mg (NDC 0002-4312-08)Reyvow, Tablet, 50 mg (NDC 0002-4312-08)Reyvow, Tablet, 50 mg (NDC 0002-4312-61)Reyvow, Tablet, 50 mg (NDC 0002-4312-61)Reyvow, Tablet, 50 mg (NDC 0002-4312-62)Reyvow, Tablet, 50 mg (NDC 0002-4312-62)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Eli Lilly6 LLY

Listed: Eli Lilly LLY · NYSE

Compared with similar medicines

ATC group N02CC · Selective Serotonin (5Ht1) Agonists
Sumatriptan13/16Eletriptan7/16Rizatriptan6/16Zolmitriptan4/16Almotriptan2/16Frovatriptan2/16Lasmiditan1/16Sumatriptan and Naproxen1/16

Affected products

CountryProductCompanySinceExpected backReason
USReyvow, Tablet, 100 mg (NDC 0002-4491-08) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated
USReyvow, Tablet, 100 mg (NDC 0002-4491-61) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated
USReyvow, Tablet, 100 mg (NDC 0002-4491-62) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated
USReyvow, Tablet, 50 mg (NDC 0002-4312-08) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated
USReyvow, Tablet, 50 mg (NDC 0002-4312-61) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated
USReyvow, Tablet, 50 mg (NDC 0002-4312-62) discontinuationEli Lilly and Co.3 Nov 2025not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Lasmiditan shortage?

Yes. As of 2 Nov 2026, Lasmiditan is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Lasmiditan be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Lasmiditan in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Lasmiditan shortages?

Eli Lilly.